Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus

NCT00611663 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

BIOLOGICAL: Prevenar® and Pneumo23®
BIOLOGICAL: Placebo, Pneumo23®

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]